Zhai’s study showed that using CRISPR/Cas9 genome editing technology to knockdown PLCE1, cell migration, and invasion were significantly inhibited by decreasing transcriptional activity of snail in ESCC [11]. Here, PLCE1 is linked to esophageal squamous cell carcinoma.